
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Vanessa Piechotta, Claire Iannizzi, Khai Li Chai, et al.
Cochrane library (2021) Vol. 2021, Iss. 5
Open Access | Times Cited: 188
Vanessa Piechotta, Claire Iannizzi, Khai Li Chai, et al.
Cochrane library (2021) Vol. 2021, Iss. 5
Open Access | Times Cited: 188
Showing 1-25 of 188 citing articles:
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
David J. Sullivan, Kelly A. Gebo, Shmuel Shoham, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 18, pp. 1700-1711
Open Access | Times Cited: 237
David J. Sullivan, Kelly A. Gebo, Shmuel Shoham, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 18, pp. 1700-1711
Open Access | Times Cited: 237
Systemic corticosteroids for the treatment of COVID-19
Carina Wagner, Mirko Griesel, Agata Mikołajewska, et al.
Cochrane library (2021) Vol. 2021, Iss. 8
Open Access | Times Cited: 203
Carina Wagner, Mirko Griesel, Agata Mikołajewska, et al.
Cochrane library (2021) Vol. 2021, Iss. 8
Open Access | Times Cited: 203
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
Fiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, et al.
PLoS Medicine (2021) Vol. 18, Iss. 7, pp. e1003656-e1003656
Open Access | Times Cited: 141
Fiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, et al.
PLoS Medicine (2021) Vol. 18, Iss. 7, pp. e1003656-e1003656
Open Access | Times Cited: 141
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19
Nina Kreuzberger, Caroline Hirsch, Khai Li Chai, et al.
Cochrane library (2021) Vol. 2021, Iss. 9
Open Access | Times Cited: 134
Nina Kreuzberger, Caroline Hirsch, Khai Li Chai, et al.
Cochrane library (2021) Vol. 2021, Iss. 9
Open Access | Times Cited: 134
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection
Ali Zhang, Hannah D. Stacey, Michael R. D’Agostino, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 6, pp. 381-396
Open Access | Times Cited: 128
Ali Zhang, Hannah D. Stacey, Michael R. D’Agostino, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 6, pp. 381-396
Open Access | Times Cited: 128
Combating Oxidative Stress and Inflammation in COVID‐19 by Molecular Hydrogen Therapy: Mechanisms and Perspectives
Duried Alwazeer, Franky Fuh-Ching Liu, Xiao Yu Wu, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 104
Duried Alwazeer, Franky Fuh-Ching Liu, Xiao Yu Wu, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 104
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 91
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 91
Remdesivir for the treatment of COVID-19
Felicitas Grundeis, Kelly Ansems, Karolina Dahms, et al.
Cochrane library (2023) Vol. 2023, Iss. 1
Closed Access | Times Cited: 83
Felicitas Grundeis, Kelly Ansems, Karolina Dahms, et al.
Cochrane library (2023) Vol. 2023, Iss. 1
Closed Access | Times Cited: 83
COVID-19 challenges and its therapeutics
Sabi Ur Rehman, Shaheed Ur Rehman, Hye Hyun Yoo
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 112015-112015
Open Access | Times Cited: 94
Sabi Ur Rehman, Shaheed Ur Rehman, Hye Hyun Yoo
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 112015-112015
Open Access | Times Cited: 94
Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19
Sixten Körper, Manfred Weiß, Daniel Zickler, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 20
Open Access | Times Cited: 83
Sixten Körper, Manfred Weiß, Daniel Zickler, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 20
Open Access | Times Cited: 83
Inhaled corticosteroids for the treatment of COVID-19
Mirko Griesel, Carina Wagner, Agata Mikołajewska, et al.
Cochrane library (2022) Vol. 2022, Iss. 3
Open Access | Times Cited: 68
Mirko Griesel, Carina Wagner, Agata Mikołajewska, et al.
Cochrane library (2022) Vol. 2022, Iss. 3
Open Access | Times Cited: 68
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels
Jens Lundgren, Birgit Grund, Christina E. Barkauskas, et al.
Annals of Internal Medicine (2021) Vol. 175, Iss. 2, pp. 234-243
Open Access | Times Cited: 65
Jens Lundgren, Birgit Grund, Christina E. Barkauskas, et al.
Annals of Internal Medicine (2021) Vol. 175, Iss. 2, pp. 234-243
Open Access | Times Cited: 65
Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma
Lise J Estcourt, Claudia S. Cohn, Monica B. Pagano, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 9, pp. 1310-1321
Open Access | Times Cited: 64
Lise J Estcourt, Claudia S. Cohn, Monica B. Pagano, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 9, pp. 1310-1321
Open Access | Times Cited: 64
SARS-CoV-2 vaccines for cancer patients: a call to action
Chiara Corti, Edoardo Crimini, Paolo Tarantino, et al.
European Journal of Cancer (2021) Vol. 148, pp. 316-327
Open Access | Times Cited: 63
Chiara Corti, Edoardo Crimini, Paolo Tarantino, et al.
European Journal of Cancer (2021) Vol. 148, pp. 316-327
Open Access | Times Cited: 63
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 62
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 62
Colchicine for the treatment of COVID-19
Agata Mikołajewska, Anna-Lena Fischer, Vanessa Piechotta, et al.
Cochrane library (2021) Vol. 2021, Iss. 10
Open Access | Times Cited: 59
Agata Mikołajewska, Anna-Lena Fischer, Vanessa Piechotta, et al.
Cochrane library (2021) Vol. 2021, Iss. 10
Open Access | Times Cited: 59
Development and application of therapeutic antibodies against COVID-19
Lin Ning, Hamza B. Abagna, Qianhu Jiang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 6, pp. 1486-1496
Open Access | Times Cited: 58
Lin Ning, Hamza B. Abagna, Qianhu Jiang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 6, pp. 1486-1496
Open Access | Times Cited: 58
SARS-CoV-2 Antiviral Therapy
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 4
Open Access | Times Cited: 57
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 4
Open Access | Times Cited: 57
Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence
Carina Wagner, Mirko Griesel, Agata Mikołajewska, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 50
Carina Wagner, Mirko Griesel, Agata Mikołajewska, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 50
Janus kinase inhibitors for the treatment of COVID-19
Andre Kramer, Carolin Prinz, Falk Fichtner, et al.
Cochrane library (2022) Vol. 2022, Iss. 6
Open Access | Times Cited: 44
Andre Kramer, Carolin Prinz, Falk Fichtner, et al.
Cochrane library (2022) Vol. 2022, Iss. 6
Open Access | Times Cited: 44
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
Evan M. Bloch, Daniele Focosi, Shmuel Shoham, et al.
Clinical Infectious Diseases (2023) Vol. 76, Iss. 11, pp. 2018-2024
Open Access | Times Cited: 37
Evan M. Bloch, Daniele Focosi, Shmuel Shoham, et al.
Clinical Infectious Diseases (2023) Vol. 76, Iss. 11, pp. 2018-2024
Open Access | Times Cited: 37
Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications
Endeshaw Chekol Abebe, Tadesse Asmamaw Dejenie
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
Endeshaw Chekol Abebe, Tadesse Asmamaw Dejenie
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
Convalescent plasma for people with COVID-19: a living systematic review
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2023, Iss. 2
Open Access | Times Cited: 31
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2023, Iss. 2
Open Access | Times Cited: 31
Convalescent plasma for people with COVID-19: a living systematic review
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2024, Iss. 2
Closed Access | Times Cited: 31
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2024, Iss. 2
Closed Access | Times Cited: 31